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of bleeding complications in patients receiving clopidogrel at the time of car-
diac device surgery.
Methods: Between July 2004 and July 2010, 101 consecutive patients
underwent cardiac device surgery (pacemaker or implantable cardioverter-
defibrillator implantation, generator replacement) under clopidogrel therapy in
our institution. Controls were 1:1 matched on age, sex, device, type of proce-
dure, number of leads implanted, and venous approach (cephalic or subcla-
vian). A significant bleeding complication was defined as pocket hematoma
requiring surgical evacuation or prolonged hospitalization, hemothorax, peri-
cardial effusion or tamponade.
Results: Bleeding complications occurred more frequently in patients
receiving clopidogrel at the time of device procedure: 11.9% vs. 4.0%
(p=0,037; OR 3.27 (1.02-10.5)). Bleeding complications were noted in
12 patients (11.9%) receiving clopidogrel, including 10 pocket haematomas,
2 patients with pericardial effusion and one patient with hemothorax. Four
controls (4.0%) had bleeding complications (3 pocket haematomas and one
pericardial effusion). The single factor associated with increased bleeding
complications in patients receiving clopidogrel was subclavian puncture
(p=0.008). In the entire cohort (n=202), multivariate analysis identified sub-
clavian puncture as the single independent predictor of bleeding complications
(p=0.02; OR 3.75 (1.23-11.4)), whereas a non-significant trend was observed
for clopidogrel treatment (p=0,08; OR 3.0 (0.87-10.3)).
Conclusion: Clopidogrel treatment at the time of heart rhythm device pro-
cedures is associated with a 3-fold increased risk of significant bleeding com-
plications. Subclavian puncture strongly increases hemorrhagic complications
in this setting, so as a cephalic cut-down first-line approach appears safer in
these patients.
253
Prevalence of heart disease in patients with paroxysmal supraventri-
cular tachycardia and prognosis
Béatrice Brembilla-Perrot [Orateur] (1), Jean Marc Sellal (1), Pierre Yves
Zinzius (1), Jérôme Schwartz (1), Daniel Beurrier (1), Anne Moulin-
Zinsch (2), Simona State (1), Soumaya Jarmouni (1), Pierre Louis (1), Olivier
Selton (1), Arnaud Terrier De La Chaise (1), Julien Delobelle (1), H Kha-
chab (1)
(1) CHU Brabois, Cardiologie, Vandoeuvre Les Nancy, France – (2) CHU
Brabois, Cardiologie Pédiatrique, Vandoeuvre Les Nancy, France
Paroxysmal supraventricular tachycardia is considered benign because it
occurs in subjects with healthy heart. When SVT occurs in patients (pts) with
heart disease (HD), the prognosis is unknown. The purpose of the study was
to report the prognosis of SVT occurring in pts with HD.
Methods: 1269 pts, aged from 6 to 93 years (mean 50±19) with a normal
ECG in sinus rhythm, without anterograde conduction through an accessory
pathway (AP) were recruited for SVT’s. Clinical history, echocardiographic
and electrophysiological data were collected. Pts were followed from 3
months to 20 years (mean 3.5±4).
Results: SVT occurred in 133 pts with HD (10%), ischemic HD (59), val-
vular HD (21), congenital HD (5), dilated cardiomyopathy (25), various HD
(23). Their mean age was 62±15 years. Remaining 1136 pts, mean age 48±19
(p<0.0000) had no apparent HD. SVT ablation was performed in 788 pts, 72
with HD (54%), 712 without HD (64%)(NS 0.055). SVT mechanism was sim-
ilar, AV reentrant tachycardia (AVRT) through concealed AP 21% in pts with
HD, 18.5% in pts without HD (NS), atypical or typical AV node RT in
remaining pts. During follow-up, 19 of 133 pts with HD (14%), 56±14.5 years
old, died from cardiovascular (CV) death (sudden death 9, heart failure-related
death 9, death after ablation in 1 old woman with aortic stenosis by collapsus).
Only 8 pts without HD, mean age 52±22, died from CV death (0.7%)
(p<0.000001) (sudden death 2, heart failure 2, SVT ablation-related death 2,
rhythmic surgery-related death 1). Three pts with SVT and HD are in stage IV
of heart failure; 13 pts with HD are in permanent atrial fibrillation (AF)
(10%); only 52 pts without HD are in AF (4.5%) (p<0.01); 3 of them died
from CV death.
Conclusions: We confirm the low risk of SVT-related death in pts without
HD. At contrary, pts with HD and SVT are at high risk of cardiovascular
events despite ablation of SVT. Sudden deaths and heart failure-related deaths
are frequent. They are also at risk of AF.
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Accessory pathway (AP) ablations have exploded in recent years and nat-
ural follow-up of preexcitation syndrome (PS) became difficult. The purpose
of the study was to report the natural changes of clinical and electrophysiolog-
ical data in patients with a PS.
Methods: Electrophysiological study (EPS) was performed in 74 patients,
mean age 31±16 with a PS and was repeated 1 to 21 years later (mean
9 years±6). EPS 1 was indicated for syncope (n=8), atrioventricular reentrant
tachycardia (AVRT) (n=39), atrial fibrillation (AF) (n=3), spontaneous
adverse presentation (n=4) or for asymptomatic PS (n=20). The protocol was
similar at both EPS.
Results: At study 2, clinical data remained unchanged in 39 patients (53%);
12 initially asymptomatic patients became symptomatic (60%); 11 initially symp-
tomatic patients became asymptomatic (20%). At EPS 2 the highest rate con-
ducted by AP was lower in control state and after isoproterenol. AP has lost
anterograde conduction in 22 patients, but 10 had still AVRT. Among 28 patients
with initially rapid conduction through AP, 5 became asymptomatic with a benign
form; 23 have still a rapid conduction at EPS 2; 3 initially asymptomatic patients
developed rapid AF. The frequency of AVRT induction was similar at EPS 1 and
2. The frequency of AF induction tended to decrease (NS).
Conclusions: A benign preexcitation syndrome without inducible AVRT
or AF remains benign. Rate conducted through AP decreases during the life,
but AVRT remains inducible. Patients with AVRT and AP with a long refrac-
tory period become asymptomatic in 15% of cases. There is a discrepancy
between clinical presentation and data of EPS.
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Accessory pathway (AP) ablation is now a current treatment of symptom-
atic patients (pts) with a Wolff-Parkinson-White (WPW) syndrome or pts with
a potentially malignant form at electrophysiological study. The success is con-
sidered as high. The purpose of the study was to look for the prevalence of the
reappearance of symptoms or preexcitation syndrome after ablation.
Methods: Successful AP ablation was performed in 327 pts aged from 10
to 77 years, mean age 35±16, with a WPW. Reappearance of symptoms or of
a preexcitation syndrome on ECG occurred in 50 patients (15%) from several
hours to several years (group I). Clinical and electrophysiological data were
studied in group I and remaining pts (group II).
Results: Group I was younger than group II (31±16 years vs 36±17,
<0.05). There were no differences concerning the gender (male 56% vs 60%)
and the reason of ablation (spontaneous malignant form 20% vs 27%; sponta-
neous AV reentrant tachycardia (AVRT) 60% vs 58%, asymptomatic with
electrophysiological signs of malignancy 20% vs 15%). There is a tendency
(0.08) for a more frequent septal AP location in group I (54%) than in
group II (41%). Other locations did not differ. During follow up, among ini-
tially asymptomatic group I pts, 2 became symptomatic and had inducible
AVRT at the control. Group I pts with spontaneous AVRT presented recur-
rences of AVRT, but 1. Among group I pts with spontaneously malignant
form, 3 pts lost the signs of malignancy at 2nd EPS; one pt who presented only
with rapid AF had an AP with long refractory period but developed incessant
AVRT’s; 6 pts had still signs of malignancy.
Conclusions: The reappearance of symptoms or a preexcitation syndrome on
ECG after AP ablation is not rare (15%) and is generally associated with the
reappearance of all initial electrophysiological properties of AP. Pts without
AVRT before ablation may become symptomatic and develop AVRT after abla-
tion. A young age and a septal AP location were factors of recurrence.
